105 related articles for article (PubMed ID: 9129128)
21. alpha2-Adrenoceptor subsensitivity in mesenteric vascular bed of cholestatic rats: the role of nitric oxide and endogenous opioids.
Borhani AA; Houshmand G; Samini M; Namiranian K; Hajrasouliha AR; Tavakoli S; Ebrahimi F; Dehpour AR
Eur J Pharmacol; 2005 May; 514(2-3):183-9. PubMed ID: 15910805
[TBL] [Abstract][Full Text] [Related]
22. Opiate antagonist therapy for the pruritus of cholestasis: the avoidance of opioid withdrawal-like reactions.
Jones EA; Neuberger J; Bergasa NV
QJM; 2002 Aug; 95(8):547-52. PubMed ID: 12145394
[TBL] [Abstract][Full Text] [Related]
23. Role of opioid and nitric oxide systems in the nonadrenergic noncholinergic-mediated relaxation of corpus cavernosum in bile duct-ligated rats.
Sadeghipour H; Dehghani M; Dehpour AR
Eur J Pharmacol; 2003 Jan; 460(2-3):201-7. PubMed ID: 12559382
[TBL] [Abstract][Full Text] [Related]
24. Effects of polyinosinic-polycytidylic acid (Poly I:C) on naloxone-precipitated withdrawal in morphine-dependent mice.
Chen L; Zhai H; Lu L; Chen S; Ning Y; Wang W
Neurosci Lett; 2011 Jan; 487(3):341-4. PubMed ID: 20974220
[TBL] [Abstract][Full Text] [Related]
25. Role of nitric oxide in catalepsy and hyperthermia in morphine-dependent rats.
Afify EA; Daabees TT; Gabra BH; Abou Zeit-Har MS
Pharmacol Res; 2001 Dec; 44(6):533-9. PubMed ID: 11735362
[TBL] [Abstract][Full Text] [Related]
26. Morphine-induced antinociception in the formalin test: sensitization and interactions with D1 and D2 dopamine receptors and nitric oxide agents.
Zarrindast MR; Asgari-Afshar A; Sahebgharani M
Behav Pharmacol; 2007 May; 18(3):177-84. PubMed ID: 17426481
[TBL] [Abstract][Full Text] [Related]
27. L-arginine exerts a dual role in nociceptive processing in the brain: involvement of the kyotorphin-Met-enkephalin pathway and NO-cyclic GMP pathway.
Kawabata A; Umeda N; Takagi H
Br J Pharmacol; 1993 May; 109(1):73-9. PubMed ID: 8388303
[TBL] [Abstract][Full Text] [Related]
28. Suppression of acute and chronic opioid withdrawal by a selective soluble guanylyl cyclase inhibitor.
Sullivan ME; Hall SR; Milne B; Jhamandas K
Brain Res; 2000 Mar; 859(1):45-56. PubMed ID: 10720614
[TBL] [Abstract][Full Text] [Related]
29. Histamine H(3) receptor modulates nociception in a rat model of cholestasis.
Hasanein P
Pharmacol Biochem Behav; 2010 Sep; 96(3):312-6. PubMed ID: 20576511
[TBL] [Abstract][Full Text] [Related]
30. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
Rehni AK; Bhateja P; Singh TG; Singh N
Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
[TBL] [Abstract][Full Text] [Related]
31. A neuroactive steroid, dehydroepiandrosterone sulfate, prevents the development of morphine dependence and tolerance via c-fos expression linked to the extracellular signal-regulated protein kinase.
Ren X; Noda Y; Mamiya T; Nagai T; Nabeshima T
Behav Brain Res; 2004 Jul; 152(2):243-50. PubMed ID: 15196791
[TBL] [Abstract][Full Text] [Related]
32. Attenuation of morphine tolerance and dependence by aminoguanidine in mice.
Abdel-Zaher AO; Hamdy MM; Aly SA; Abdel-Hady RH; Abdel-Rahman S
Eur J Pharmacol; 2006 Jul; 540(1-3):60-6. PubMed ID: 16730698
[TBL] [Abstract][Full Text] [Related]
33. Further in vivo studies on attenuating morphine withdrawal: isoform-selective nitric oxide synthase inhibitors differ in efficacy.
Vaupel DB; Kimes AS; London ED
Eur J Pharmacol; 1997 Apr; 324(1):11-20. PubMed ID: 9137908
[TBL] [Abstract][Full Text] [Related]
34. The effect of cholestasis on rewarding and exploratory behaviors induced by opioidergic and dopaminergic agents in mice.
Ebrahimi-ghiri M; Nasehi M; Rostami P; Mohseni-Kouchesfehani H; Zarrindast MR
Arch Iran Med; 2012 Oct; 15(10):617-24. PubMed ID: 23020537
[TBL] [Abstract][Full Text] [Related]
35. Suppression of naloxone-precipitated withdrawal jumps in morphine-dependent mice by stimulation of prostaglandin EP3 receptor.
Nakagawa T; Minami M; Katsumata S; Ienaga Y; Satoh M
Br J Pharmacol; 1995 Nov; 116(6):2661-6. PubMed ID: 8590986
[TBL] [Abstract][Full Text] [Related]
36. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
Crain SM; Shen KF
Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
[TBL] [Abstract][Full Text] [Related]
37. Florid opioid withdrawal-like reaction precipitated by naltrexone in a patient with chronic cholestasis.
Jones EA; Dekker LR
Gastroenterology; 2000 Feb; 118(2):431-2. PubMed ID: 10648471
[TBL] [Abstract][Full Text] [Related]
38. Further evidence that nitric oxide modifies acute and chronic morphine actions in mice.
Pataki I; Telegdy G
Eur J Pharmacol; 1998 Sep; 357(2-3):157-62. PubMed ID: 9797031
[TBL] [Abstract][Full Text] [Related]
39. Diazepam pretreatment suppresses morphine withdrawal signs in the mouse.
Suzuki T; Tsuda M; Narita M; Funada M; Mizoguchi H; Misawa M
Life Sci; 1996; 58(4):349-57. PubMed ID: 8538371
[TBL] [Abstract][Full Text] [Related]
40. Nitric oxide synthesis inhibition attenuates behavioral actions of neuropeptide FF.
Malin DH; Lake JR; Jones JA; Morel J; Moon WD; Corbit BP; Smith DA; Claunch AE; Kacher D; Stevens PA; Webb SL
Peptides; 1996; 17(4):615-8. PubMed ID: 8804070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
